|
Volumn 12, Issue 5, 2005, Pages 387-388
|
An Achilles' heel for breast cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CISPLATIN;
CYTOTOXIC AGENT;
MITOMYCIN C;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
BREAST CANCER;
CANCER GENETICS;
CANCER THERAPY;
DNA REPAIR;
GENE MUTATION;
HUMAN;
NONHUMAN;
ONCOGENE;
PRIORITY JOURNAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TARGET CELL DESTRUCTION;
TUMOR CELL;
TUMOR SUPPRESSOR GENE;
ANIMAL;
ARTICLE;
BREAST TUMOR;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
METABOLISM;
PATHOLOGY;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
BREAST NEOPLASMS;
DNA REPAIR;
ENZYME INHIBITORS;
POLY(ADP-RIBOSE) POLYMERASES;
|
EID: 20444461647
PISSN: 15459993
EISSN: 15459985
Source Type: Journal
DOI: 10.1038/nsmb0505-387 Document Type: Short Survey |
Times cited : (4)
|
References (16)
|